Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat

Drug Metabolism and Disposition

Volumn 28, Issue 5, 2000, Pages 503-513

  Mountfield, Richard J ^a,c   Kiehr, Benedicte ^a   John, Brian A ^b  

^a NOVO NORDISK A S   (Denmark)

^b HLS Ltd   (United Kingdom)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CENTCHROMAN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; BILE; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTROGEN RECEPTOR MODULATORS; FECES; FEMALE; HALF-LIFE; MALE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0034095017     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bain S, Shalmi M and Korsgaard N (1997) Levormeloxifene, a non-steroidal estrogen receptor therapeutic, prevents bone loss, reduces serum cholesterol and has differentiated uterine effects in the ovariectomised rat. Maturitas 27:144.
2. Dodge JA, Lugar CW, Cho S, Short LL, Sato M, Yang NN, Spangle LA, Martin MJ, Phillips DL, Glasebrook AL, Osborne JJ, Frolik CA and Bryant HU (1997) Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity. J Steroid Biochem Mol Biol 61:97-106.
3. Heinzel G, Woloszszak R and Thomann P (1993) TopFit version 2.0 Pharmacokinetic and pharmacodynamic data analysis system for the PC. Gustav Fischer, Verlag.
4. Holm P, Shalmi M, Korsgaard N, Guldhammer B, Skouby SO and Stender S (1997) A partial estrogen receptor agonist with strong antiatherogenic properties without noticeable effect on reproductive tissue in cholesterol-fed female and male rabbits. Arterioscler Thromb Vasc Biol 17:2264-2272.
5. Korsgaard N, Greenspan DL, Kurman R and Bain S (1997) Levormeloxifene, a non-steroidal estrogen receptor therapeutic, exerts a non-proliferative action on uterine tissues of the ovariectomised rat. Maturitas 27:144.
6. Kuiper GG, Carlsson B. Grandien K, Enmark E, Haggblad J, Nilsson S and Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.
7. Kuipers F, Dijkstra T, Havinga R, van Asselt W and Vonk RJ (1985a) Acute effects of pentobarbital-anaesthesia on bile secretion. Biochem Pharmacol 34:1731-1736.
8. Kuipers F, Havinga R, Bosschiter H, Toorop GP, Hindriks FR and Vonk RJ (1985b) Enterohepatic circulation in the rat. Gastroenterology 88:403-411.
9. Lindstrom TD, Whitaker NG and Whitaker GW (1984) Disposition and metabolism of a new benzothiophene antiestrogen in rats, dogs, and monkeys. Xenobiotica 11:841-847.
10. Mountfield RJ, Panduro AM, Wassmann O, Thompson M, John B and Van Der Merbel N (2000) Metabolism of levormeloxifene, a selective estrogen receptor modulator, in the Sprague Dawley rat, Cynomolgus monkey, and postmenopausal women. Xenobiotica 30:201-217.
11. Mugford CA and Kedderis GL (1998) Sex dependent metabolism of xenobiotics. Drug Metab Rev 30:441-498.
12. O'Donnell JP, Khosla NB and Dalvie DK (1998) Metabolism of droloxifene in the CD-1 mouse, Fischer-344 rat and cynomolgus monkey. Xenobiotica 28:153-166.
13. Remie R, Rensema JW, Havinga R and Kuipers F (1991) The permanent bile fistula rat model. in Progress in Pharmacology and Clinical Pharmacology (Siegers C and Watkins JB eds) vol. 8(4), pp. 127-145, Gustav Fischer Verlag Press, New York.
14. Tanaka Y, Sekiguchi M, Sawamoto T, Hata T, Esumi Y, Sugai S and Ninomiya S (1994) Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients. Eur J Drug Metab Pharmacokinet 19:47-58.
15. Ullberg S and Larrson B (1981) Whole-body autoradiography, in Progress in Drug Metabolism (Bridges JW and Chasseau LF eds) pp 249-288, John Wiley, New York.
16. Witt DM and Lousberg TR (1997) Controversies surrounding estrogen use in postmenopausal women. Ann Pharmacother 31:745-755.